Epidemiology of haemodialysis outcomes
Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
Diabetic kidney disease: a report from an ADA Consensus Conference
KR Tuttle, GL Bakris, RW Bilous, JL Chiang… - Diabetes …, 2014 - Am Diabetes Assoc
The incidence and prevalence of diabetes mellitus have grown significantly throughout the
world, due primarily to the increase in type 2 diabetes. This overall increase in the number of …
world, due primarily to the increase in type 2 diabetes. This overall increase in the number of …
[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
[HTML][HTML] Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
CA Herzog, RW Asinger, AK Berger, DM Charytan… - Kidney international, 2011 - Elsevier
Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high,
and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is …
and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is …
[HTML][HTML] Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
K Kalantar-Zadeh, N Kuwae, DL Regidor… - Kidney international, 2006 - Elsevier
Although renal osteodystrophy and vitamin D analogs may be related to survival in
maintenance hemodialysis (MHD) patients, most studies have examined associations …
maintenance hemodialysis (MHD) patients, most studies have examined associations …
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis
K Kalantar-Zadeh, DL Regidor, CP Kovesdy… - Circulation, 2009 - Am Heart Assoc
Background—Patients with chronic kidney disease (stage 5) who undergo hemodialysis
treatment have similarities to heart failure patients in that both populations retain fluid …
treatment have similarities to heart failure patients in that both populations retain fluid …
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial
R Agarwal, AD Sinha, MK Pappas… - Nephrology Dialysis …, 2014 - academic.oup.com
Background The purpose of this study was to determine among maintenance hemodialysis
patients with echocardiographic left ventricular hypertrophy and hypertension whether in …
patients with echocardiographic left ventricular hypertrophy and hypertension whether in …
Serum and dialysate potassium concentrations and survival in hemodialysis patients
CP Kovesdy, DL Regidor, R Mehrotra… - Clinical Journal of the …, 2007 - journals.lww.com
Serum and Dialysate Potassium Concentrations and Survival in... : Clinical Journal of the
American Society of Nephrology Serum and Dialysate Potassium Concentrations and Survival in …
American Society of Nephrology Serum and Dialysate Potassium Concentrations and Survival in …
Exercise in the end-stage renal disease population
KL Johansen - Journal of the American Society of Nephrology, 2007 - journals.lww.com
Many of the known benefits of exercise in the general population are of particular relevance
to the ESRD population. In addition, the poor physical functioning that is experienced by …
to the ESRD population. In addition, the poor physical functioning that is experienced by …
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
DL Regidor, JD Kopple, CP Kovesdy… - Journal of the …, 2006 - journals.lww.com
Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents
(ESA) may improve survival, most studies have examined associations between baseline …
(ESA) may improve survival, most studies have examined associations between baseline …